SEC Form 4 · accession 0001209191-15-059104
Paratek Pharmaceuticals, Inc. · PRTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Evan Loh
Officer — President and CMO · Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178711
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | A | 30,000 | $0.00 | A | 74,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $25.77 | Jun 30, 2015 | A | 60,000 | A | — | Jun 29, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
- F2The shares shall vest in 36 equal monthly installments measured commencing from June 30, 2015.